Back to top
more

Better trading starts here.

Brokerage Reports

Research for DVA

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

0 items in cart

DaVita Inc. [DVA]

Reports for Purchase

Showing records 181 - 200 ( 289 total )

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 181

02/01/2016

Company Report

Pages: 8

Price: 24.95

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 182

01/27/2016

Company Report

Pages: 8

Price: 24.95

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 183

01/14/2016

Company Report

Pages: 8

Price: 24.95

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 184

01/08/2016

Company Report

Pages: 8

Price: 24.95

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 185

01/07/2016

Company Report

Pages: 8

Price: 24.95

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 186

01/04/2016

Company Report

Pages: 8

Price: 24.95

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 187

12/01/2015

Company Report

Pages: 8

Price: 24.95

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 188

11/03/2015

Daily Note

Pages: 8

Raising Estimates Slightly as Capital Deployment Offsets Lower HCP

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 25.00

Research Provided by a Third Party

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 189

10/26/2015

Company Report

Pages: 8

Price: 24.95

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 190

10/06/2015

Company Report

Pages: 8

Price: 24.95

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 191

10/05/2015

Company Report

Pages: 8

Price: 24.95

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 192

09/02/2015

Company Report

Pages: 8

Price: 24.95

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 193

08/07/2015

Company Report

Pages: 8

Price: 24.95

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 194

08/06/2015

Company Report

Pages: 7

Reducing EPS Estimates Slightly on a Relatively Quiet Quarter

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 25.00

Research Provided by a Third Party

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 195

07/23/2015

Company Report

Pages: 8

Price: 24.95

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 196

06/09/2015

Company Report

Pages: 8

Price: 24.95

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 197

05/12/2015

Company Report

Pages: 9

Raising Estimates Slightly on Guidance and Buybacks

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 25.00

Research Provided by a Third Party

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 198

05/08/2015

Company Report

Pages: 8

Price: 24.95

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 199

05/04/2015

Daily Note

Pages: 3

ALERT: Raises Full-Year Guidance Despite Slightly Light 1Q

Provider: KEYBANC CAPITAL MARKETS

Analyst: GURDA J

Price: 10.00

Research Provided by a Third Party

Company: DaVita Inc.

Industry: Medical - Outpatient and Home Healthcare

Record: 200

04/16/2015

Company Report

Pages: 8

Price: 24.95